Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?

Med Hypotheses. 2020 Nov:144:109975. doi: 10.1016/j.mehy.2020.109975. Epub 2020 Jun 8.

Authors

Aliae A R Mohamed-Hussein¹, Karim M E Aly², Mohamed-Eltaher A A Ibrahim³

Affiliations

¹ Department of Pulmonology, Assiut University Hospitals, Assiut, Egypt.
² Cardiology Department, Assiut University Hospitals, Assiut, Egypt.
³ Tropical, Gastroenterology and Hepatology Department, Alrajhi Hospital, Assiut University Hospitals, Assiut, Egypt.

No abstract available

Publication types

Letter

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Anticoagulants / therapeutic use
Aspirin / therapeutic use*
Autopsy
Blood Coagulation Disorders / prevention & control*
Blood Coagulation Disorders / virology
COVID-19 / complications*
COVID-19 Drug Treatment*
Hemorrhage / prevention & control
Hemorrhage / virology
Humans
Models, Theoretical
Stroke / complications
Stroke / prevention & control

Substances

Anti-Inflammatory Agents, Non-Steroidal
Anticoagulants
Aspirin